These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 3278937

  • 1. Urinary excretion of beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase in advanced neuroblastoma patients receiving cis-diamminedichloroplatinum(II).
    Ikeda H, Nagashima K, Okumura H, Takahashi A, Matsuyama S, Nagamachi Y.
    Eur J Surg Oncol; 1988 Feb; 14(1):17-20. PubMed ID: 3278937
    [Abstract] [Full Text] [Related]

  • 2. [Determination of urinary N-acetyl-beta-D-glucosaminidase (NAG) excretion as a parameter of nephrotoxicity due to cis-platin and the effect of fosfomycin (FOM) on its nephrotoxicity].
    Matsuoka R, Inoue T, Miyamura K, Mizutani K, Koike S, Mori H, Kigawa T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov; 38(11):2037-44. PubMed ID: 3794453
    [Abstract] [Full Text] [Related]

  • 3. [A clinical evaluation of the protective effect of fosfomycin (FOM) against the cis-diamminedichloroplatinum (CDDP)-induced nephrotoxicity].
    Saito M, Masaki T, Kato H, Numasaka K.
    Hinyokika Kiyo; 1988 May; 34(5):782-9. PubMed ID: 3051938
    [Abstract] [Full Text] [Related]

  • 4. [Clinical investigation of cis-platinum nephrotoxicity in 244 cases of primary lung cancer].
    Soejima A, Inoue T, Suzuki M, Waku M, Nakabayashi K, Kitamoto K, Nagasawa T.
    Nihon Jinzo Gakkai Shi; 1992 Jul; 34(7):801-6. PubMed ID: 1479719
    [Abstract] [Full Text] [Related]

  • 5. [Comparison of methods for evaluating the nephrotoxicity of cisplatin].
    Suzumori K, Yasui Y, Suzumori K, Yagami Y, Seki T.
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2251-6. PubMed ID: 3044273
    [Abstract] [Full Text] [Related]

  • 6. [Relation of enzyme distribution in the kidney and increase pattern of urinary N-acetyl-beta-D-glucosaminidase (NAG) and gamma-glutamyl transpeptidase (gamma-GTP) activities following CDDP administration].
    Takahashi T, Yoshida K, Nakame Y, Saitoh H.
    Hinyokika Kiyo; 1987 Oct; 33(10):1569-74. PubMed ID: 2895573
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Effects of combination chemotherapy with cis-diamminedichloroplatinum (II) (CDDP) on renal function in patients with urogenital malignancies].
    Kawamura J, Hida S, Higashi Y, Yamauchi T, Soeda A, Yoshida O.
    Hinyokika Kiyo; 1985 Feb; 31(2):207-21. PubMed ID: 4040315
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Antineoplastic therapy and urinary enzymes. Preliminary note on the determination of urinary N-acetyl-beta-D-glucosaminidase in patients treated with cisplatin].
    Crovato E, Salvini R.
    Boll Soc Ital Biol Sper; 1984 Dec 30; 60(12):2255-60. PubMed ID: 6543318
    [Abstract] [Full Text] [Related]

  • 11. [Urinary excretion of N-acetyl-beta-D-glucosaminidase in patients with urological disease: with special reference to hydronephrosis].
    Ueda K, Kato J, Seki T.
    Hinyokika Kiyo; 1984 Jul 30; 30(7):877-82. PubMed ID: 6391119
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Influences of percutaneous nephrolithotomy on renal function, an observation using the NAG-index and beta 2-microglobulin as indices].
    Yajima I, Nishimura T, Yoshida K, Tomita M, Hikima N, Kawamura N, Tsuboi N, Honda R, Akimoto M.
    Hinyokika Kiyo; 1987 May 30; 33(5):662-8. PubMed ID: 3310555
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzyme B as a marker of the nephrotoxicity of gentamicin: re-test from an animal model].
    Ali-Miraftab H, Bourbouze R, Bondiou MT, Percheron F.
    Pathol Biol (Paris); 1988 Mar 30; 36(3):240-4. PubMed ID: 3283687
    [Abstract] [Full Text] [Related]

  • 17. N-acetyl-beta-D-glucosaminidase and beta2-microglobulin: prognostic markers in idiopathic nephrotic syndrome.
    Fede C, Conti G, Chimenz R, Ricca M.
    J Nephrol; 1999 Mar 30; 12(1):51-5. PubMed ID: 10203005
    [Abstract] [Full Text] [Related]

  • 18. [Excretion of N-acetyl-beta-D-glucosaminidase in the urine of children with type I juvenile diabetes mellitus and of patients treated with the aminoglycoside amikacin].
    Wiesmann U, Peheim E, Colombo JP.
    Klin Wochenschr; 1989 Mar 30; 67 Suppl 17():40-3. PubMed ID: 2739356
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Contribution of glycemic control to the levels of urinary N-acetyl-beta-D-glucosaminidase (NAG), total protein, beta 2-microglobulin and serum NAG in type 1 (insulin-dependent) diabetes mellitus without macroalbuminuria.
    Watanabe Y, Nunoi K, Maki Y, Nakamura Y, Fujishima M.
    Clin Nephrol; 1987 Nov 30; 28(5):227-31. PubMed ID: 3322619
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.